Project Darwin Lamarck (Non Confidential)

Drug Development

[EXCERPT]…Alxerion in only 12 months, has been able to build two promising pharmaceutical programs, an exosome program composed by 5 different subprograms for cancer and antibiotics, and a small molecule program composed by one subprogram for Hemostasis formed by a promising new family of selective serine protease inhibitors (SERPIN, antifibrinolytics) with a potent anti-plasmin and anti-tPA activity. In the next few months, ALX-051 the most advanced active compound of the new SERPIN family will enter the clinical phases of clinical development.

Download PDF